| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |